Study participants may transition from the rivaroxaban arm to abelacimab in an extension study
News | Cardiovascular Clinical Studies
Study Confirming Overwhelming Reduction in Bleeding of the Dual-Acting Factor XI/XIa Inhibitor Abelacimab as Compared to Rivaroxaban Selected as Late-Breaker Oral Presentation at the American Heart Association Scientific Sessions

September 26, 2023 — Anthos Therapeutics, Inc., a clinical stage company developing innovative therapies for ...

Home September 26, 2023
Home
Patents cover MyoVista Wavelet Technology utilizing AI for early detection of heart disease
News | ECG
HeartSciences Receives Two New Patent Allowances, Expanding its International Patent Portfolio

September 26, 2023 — Heart Test Laboratories, Inc., an AI-powered medical technology company focused on transforming ...

Home September 26, 2023
Home
New research from the Smidt Heart Institute shows that heart attack patients who also had COVID-19 were three times more likely to die in the hospital
News | Coronavirus (COVID-19)
Study: Heart Attack Outcomes Far Worse for Those With COVID-19

September 26, 2023 — New research from the Smidt Heart Institute at Cedars-Sinai shows that patients who went to a ...

Home September 26, 2023
Home
Feature | TCT
Cardiovascular Research Foundation Preps Program for Scientific Symposium, TCT 2023

September 26, 2023 — The Cardiovascular Research Foundation's (CRF) annual scientific symposium, the Transcatheter ...

Home September 26, 2023
Home
Videos | Pharmaceuticals
VIDEO, Part 3: Award-winning Researcher Shares Update on Hypertrophic Cardiomyopathy Work and Value of Mentoring

In this third and final segment in DAIC’s “One on One” series with Dr. Christine Seidman, learn what’s on the horizon at ...

Home September 26, 2023
Home
Xenotransplant surgery in progress. Image courtesy of the University of Maryland School of Medicine 
News | Heart Failure
UM Medicine Faculty-Scientists and Clinicians Perform Second Historic Transplant of Pig Heart into Patient with End-Stage Cardiovascular Disease

September 25, 2023 — After world’s first successful transplant in 2022, also performed at the University of Maryland ...

Home September 25, 2023
Home
Company’s artificial intelligence technology shows better results in early detection and patient care
News | Artificial Intelligence
New Clinical Data Supports Viz.ai Solution for Improved Pulmonary Embolism Detection and Care Coordination

September 25, 2023 — Viz.ai, a leader in AI-powered disease detection and intelligent care coordination, today announced ...

Home September 25, 2023
Home
Smidt Heart Institute investigators say condition, apparent resistant hypertension, is common, and a particular medication may get patients’ disease under control
News | Hypertension
Novel Study Deepens Knowledge of Treatment-Resistant Hypertension

September 22, 2023 — For many patients with hypertension--an elevated blood pressure that can lead to stroke or heart ...

Home September 22, 2023
Home
Advanced medical device reprocessor launches free tool to help hospitals quantify the reduction in carbon emissions possible with a proper EP reprocessing program
News | EP Lab
Innovative Health Brings EP Labs’ Carbon Emissions into Focus with New Sustainability Calculator

September 22, 2023 — Innovative Health, Inc. launched a new educational initiative and free online tool to help hospital ...

Home September 22, 2023
Home
New Board would recognize evolution of cardiology into distinct medical specialty
News | Cardiovascular Business
Cardiovascular Organizations Pursue New, Independent Medical Board

September 21, 2023 — Many of the nation’s most prominent cardiovascular organizations, representing tens of thousands of ...

Home September 21, 2023
Home
Cardiovascular disease remains the leading cause of death for both men and women
News | Cardiac Imaging
Low-income Country Cardiac Imaging Procedures Remain Down Post-COVID

September 21, 2023 — Declines in cardiovascular procedure volumes observed early in the COVID-19 pandemic greatly ...

Home September 21, 2023
Home
Vektor’s leadership team named HRX AbstracX Innovators, presenting groundbreaking studies on CT scar imaging and wall thickness analysis at HRX 2023
News | HRS
Vektor Medical Unveils Cutting-Edge, AI-based Arrhythmia Research at HRX 2023

September 21, 2023 — Vektor Medical, developers of the only FDA-cleared technology to accurately map arrhythmias using ...

Home September 21, 2023
Home
HeartSciences and Icahn Mount Sinai have also entered into a memorandum of understanding for ongoing cooperation encompassing de-identified data access
News | Artificial Intelligence
HeartSciences Signs Definitive Agreements with the Icahn School of Medicine at Mount Sinai to Commercialize Artificial Intelligence Cardiovascular Algorithms

September 21, 2023 — Heart Test Laboratories, Inc., an AI-powered medical technology company focused on transforming ...

Home September 21, 2023
Home
IDE supported by data from the MODERATO II randomized pilot study that showed AVIM therapy drove significant and sustained reductions in blood pressure in hypertensive pacemaker patients
News | Hypertension
Orchestra BioMed Granted FDA Approval of IDE to Initiate BACKBEAT Pivotal Study of BackBeat CNT for the Treatment of Hypertension in Pacemaker Patients

September 20, 2023 — Orchestra BioMed Holdings, Inc., a biomedical company accelerating high-impact technologies to ...

Home September 20, 2023
Home
IDE supported by data from the MODERATO II randomized pilot study that showed AVIM therapy drove significant and sustained reductions in blood pressure in hypertensive pacemaker patients
News | Heart Valve Technology
Minneapolis Heart Institute Foundation Launches the PROGRESS Clinical Trial to Examine the Safety and Effectiveness of Transcatheter Valve Replacement in Patients with Moderate, Calcific Aortic Stenosis

September 20, 2023 — The Minneapolis Heart Institute Foundation (MHIF), an internationally renowned cardiovascular ...

Home September 20, 2023
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now